Advanced
  Home Compare Reports

Comparison with Similar Reports

Healthcare IT Market by Products & Services (Healthcare Provider Solutions, Healthcare Payer Solutions, & HCIT Outsourcing Services), Components (Serv...

Publisher:        MarketsandMarkets

# of Pages:        479

Rating: 

1 User License $8,150

Publication Date:  August, 2021

Price:       $8,150 / User License




1 INTRODUCTION 58
1.1 OBJECTIVES OF THE STUDY 58
1.2 MARKET DEFINITION & SCOPE 58
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 58
1.2.2 MARKET SEGMENTATION 59
FIGURE 1 HEALTHCARE IT MARKET SEGMENTATION 59
1.2.3 YEARS CONSIDERED FOR THE STUDY 60
1.3 CURRENCY 60
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 60
1.4 STAKEHOLDERS 61
1.5 SUMMARY OF CHANGES 61
1.6 LIMITATIONS 62
2 RESEARCH METHODOLOGY 63
2.1 RESEARCH APPROACH 63
2.2 RESEARCH METHODOLOGY DESIGN 63
FIGURE 2 HEALTHCARE IT MARKET: RESEARCH DESIGN 63
2.2.1 SECONDARY RESEARCH 64
2.2.2 KEY DATA FROM SECONDARY SOURCES 65
2.2.3 PRIMARY DATA 66
FIGURE 3 PRIMARY SOURCES 66
2.2.4 KEY DATA FROM PRIMARY SOURCES 67
2.2.5 INSIGHTS FROM PRIMARY EXPERTS 68
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 68
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 69
2.3 MARKET SIZE ESTIMATION: HEALTHCARE IT MARKET 69
FIGURE 6 MARKET SIZE ESTIMATION: HEALTHCARE IT MARKET 69
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 70
FIGURE 8 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: HEALTHCARE IT MARKET 71
FIGURE 9 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EHR MARKET 71
FIGURE 10 BOTTOM-UP APPROACH: END-USER ADOPTION - EHR MARKET 72
FIGURE 11 TOP-DOWN APPROACH 73
FIGURE 12 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HEALTHCARE IT MARKET
(2021–2026) 74
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 74
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 76
FIGURE 14 DATA TRIANGULATION METHODOLOGY 76
2.5 MARKET SHARE ESTIMATION 77
2.6 ASSUMPTIONS FOR THE STUDY 77
2.7 LIMITATIONS 78
2.7.1 METHODOLOGY-RELATED LIMITATIONS 78
2.7.2 SCOPE-RELATED LIMITATIONS 78
2.8 RISK ASSESSMENT 78
TABLE 2 RISK ASSESSMENT: HEALTHCARE IT MARKET 78
3 EXECUTIVE SUMMARY 79
FIGURE 15 HEALTHCARE IT MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD BILLION) 79
FIGURE 16 CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 80
FIGURE 17 NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 81
FIGURE 18 HCIT OUTSOURCING SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD BILLION) 82
FIGURE 19 HEALTHCARE IT MARKET, BY END USER, 2021 VS. 2026 (USD BILLION) 82
FIGURE 20 HEALTHCARE IT MARKET, BY COMPONENT, 2021 VS. 2026 (USD BILLION) 83
FIGURE 21 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE IT MARKET 84
4 PREMIUM INSIGHTS 85
4.1 HEALTHCARE IT MARKET OVERVIEW 85
FIGURE 22 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS & HIGH RETURNS ON INVESTMENT FOR HEALTHCARE IT SOLUTIONS TO DRIVE MARKET GROWTH 85
4.2 HEALTHCARE IT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 86
FIGURE 23 CHINA TO WITNESS THE HIGHEST GROWTH IN THE HEALTHCARE IT MARKET DURING THE FORECAST PERIOD 86
4.3 NORTH AMERICA: HEALTHCARE IT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2020) 87
FIGURE 24 HEALTHCARE PROVIDER SOLUTIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN HEALTHCARE IT MARKET IN 2020 87
4.4 REGIONAL MIX: HEALTHCARE IT MARKET (2021–2026) 88
FIGURE 25 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026) 88
4.5 HEALTHCARE IT MARKET: DEVELOPED VS. DEVELOPING MARKETS 88
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH FROM 2021 TO 2026 88
5 MARKET OVERVIEW 89
5.1 INTRODUCTION 89
5.2 MARKET DYNAMICS 89
FIGURE 27 HEALTHCARE IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 89
5.2.1 KEY MARKET DRIVERS 90
5.2.1.1 Government mandates & support for healthcare IT solutions 90
TABLE 3 KEY GOVERNMENT INITIATIVES FOR EMR 91
5.2.1.2 Rising use of big data 92
5.2.1.3 High returns on investment associated with healthcare IT solutions 92
5.2.1.4 Need to curtail escalating healthcare costs 93
FIGURE 28 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION) 93
5.2.1.5 Growing adoption of e-prescribing, telehealth, mHealth, and other HCIT solutions due to COVID-19 94
5.2.1.6 Growing mHealth, telehealth, and remote patient monitoring markets 94
5.2.2 KEY MARKET RESTRAINTS 95
5.2.2.1 IT infrastructural constraints in developing countries 95
5.2.2.2 High cost of deployment of HCIT solutions for small and medium-sized hospitals in emerging countries 95
5.2.2.3 Resistance from traditional healthcare providers 96
5.2.3 KEY MARKET OPPORTUNITIES 96
5.2.3.1 Rising use of healthcare IT solutions in outpatient care facilities 96
5.2.3.2 Cloud-based EHR solutions 96
5.2.3.3 Shift towards patient-centric healthcare delivery 97
5.2.4 KEY MARKET CHALLENGES 97
5.2.4.1 Security concerns 97
FIGURE 29 US: NUMBER OF DATA BREACHES (2005–2020) 98
TABLE 4 LARGEST HEALTHCARE DATA BREACHES IN THE WORLD (2020) 98
5.2.4.2 Interoperability issues 99
5.3 COVID-19 IMPACT ON THE HEALTHCARE IT MARKET 99
5.4 PRICING ANALYSIS 100
TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2020 100
5.5 PORTER’S FIVE FORCES ANALYSIS 102
FIGURE 30 DEGREE OF COMPETITION IS HIGH IN THE HEALTHCARE IT MARKET 102
TABLE 6 HEALTHCARE IT MARKET: PORTER’S FIVE FORCES ANALYSIS 102
5.6 REGULATORY ANALYSIS 104
5.6.1 NORTH AMERICA 104
5.6.2 EUROPE 105
5.6.3 ASIA PACIFIC 105
5.6.4 MIDDLE EAST & AFRICA 106
5.6.5 LATIN AMERICA 106
5.7 ECOSYSTEM ANALYSIS 107
FIGURE 31 ECOSYSTEM ANALYSIS: HEALTHCARE IT MARKET 107
6 INDUSTRY INSIGHTS 108
6.1 US: EVOLUTION OF HEALTHCARE INFORMATION TECHNOLOGY 108
FIGURE 32 US: EVOLUTION OF HCIT 109
6.2 INDUSTRY TRENDS 110
6.2.1 TECHNOLOGY GIANTS ENTERING THE HEALTHCARE IT MARKET 110
6.2.2 BIG DATA IN HEALTHCARE 111
6.2.3 CLOUD COMPUTING 111
TABLE 7 KEY CLOUD COMPUTING TOOLS & SAAS AVAILABLE IN THE MARKET 112
6.2.4 SMART ON FHIR 112
6.3 ADOPTION TRENDS 113
6.3.1 NORTH AMERICA: ADOPTION TRENDS 113
TABLE 8 US: INPATIENT EMR ADOPTION MODEL (EMRAM), 2017 113
FIGURE 33 US: HOSPITAL EHR ADOPTION (2007–2018) 114
FIGURE 34 US: OUTPATIENT EMR ADOPTION, Q2 2017 114
6.3.2 EUROPE: ADOPTION TRENDS 115
FIGURE 35 EUROPE: EHEALTH PRIORITIES IN HEALTH FACILITIES, 2019 115
TABLE 9 EHEALTH PRIORITIES FOR HEALTHCARE PROVIDERS IN EUROPE, BY COUNTRY 116
FIGURE 36 EUROPE: EHEALTH CHALLENGES FACED BY HEALTHCARE PROVIDERS, 2019 117
6.3.3 ASIA PACIFIC: ADOPTION TRENDS 117
FIGURE 37 ASIA PACIFIC: EMR & EHR ADOPTION RATES (2012 VS. 2015) 117
6.3.4 REST OF THE WORLD: ADOPTION TRENDS 118
6.4 TECHNOLOGY ANALYSIS 118
6.4.1 MACHINE LEARNING 118
6.4.2 ARTIFICIAL INTELLIGENCE 118
6.4.3 INTERNET OF THINGS 118
6.4.4 BLOCKCHAIN 118
6.4.5 AUGMENTED REALITY 119
6.5 POTENTIAL HEALTHCARE IT TECHNOLOGIES 119
6.5.1 AI PLATFORMS 119
6.5.2 APP-ENABLED PATIENT PORTALS 119
6.5.3 MEDICAL DEVICE DATA INTEGRATION INTO CARE DELIVERY PROCESSES 120
6.6 AI IN HEALTHCARE MARKET 120
TABLE 10 AI IN HEALTHCARE MARKET, BY REGION, 2017–2026 (USD MILLION) 121
7 HEALTHCARE IT MARKET, BY PRODUCT & SERVICE 122
7.1 INTRODUCTION 123
TABLE 11 HEALTHCARE IT MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 123
7.2 HEALTHCARE PROVIDER SOLUTIONS 123
TABLE 12 HEALTHCARE PROVIDER SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 13 HEALTHCARE PROVIDER SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.1 CLINICAL HEALTHCARE IT SOLUTIONS 124
TABLE 14 CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 15 CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
7.2.1.1 Electronic health records 126
7.2.1.1.1 The adoption of electronic health records is growing significantly in emerging countries 126
TABLE 16 EHR/EMR SOLUTIONS OFFERED BY KEY MARKET PLAYERS 127
TABLE 17 ELECTRONIC HEALTH RECORDS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
FIGURE 38 EHR/EMR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 128
7.2.1.2 Population health management solutions 129
7.2.1.2.1 PHM solutions aggregate and provide a wide range of data for providers 129
TABLE 18 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS 129
TABLE 19 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 132
7.2.1.3 Specialty information management systems 132
7.2.1.3.1 Increasing number of surgical procedures conducted globally is a key factor driving market growth 132
TABLE 20 SPECIALTY INFORMATION MANAGEMENT SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 133
7.2.1.4 PACS & VNA 133
7.2.1.4.1 Growing volume of imaging procedures performed to drive the demand for these solutions 133
TABLE 21 PACS AND VNA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 134
FIGURE 39 PACS AND VNA MARKET: END-USER ASSESSMENT (2020) 135
7.2.1.5 Mobile health applications 135
7.2.1.5.1 Growing preference for self-care management has propelled the penetration of healthcare applications 135
TABLE 22 MEDICAL APPS OFFERED BY KEY MARKET PLAYERS 136
TABLE 23 MOBILE HEALTH APPLICATIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
7.2.1.6 HCIT integration systems 137
7.2.1.6.1 Integration engines help develop data interfaces quickly 137
TABLE 24 HEALTHCARE INTEGRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 137
TABLE 25 HCIT INTEGRATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.2.1.7 Telehealth solutions 138
7.2.1.7.1 The adoption of these solutions has increased due to the COVID-19 pandemic 138
TABLE 26 TELEHEALTH PLATFORMS OFFERED BY KEY MARKET PLAYERS 139
TABLE 27 TELEHEALTH SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
FIGURE 40 TELEHEALTH SOLUTIONS: END-USER ASSESSMENT (2020) 140
7.2.1.8 Medical image analysis systems 141
7.2.1.8.1 North America dominates the medical image analysis systems market 141
TABLE 28 MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
FIGURE 41 MEDICAL IMAGE ANALYSIS SYSTEMS MARKET: END-USER ASSESSMENT (2020) 142
7.2.1.9 Laboratory information systems 143
7.2.1.9.1 The need for accurate, efficient, and rapid transfer of lab results across networks is driving market growth 143
TABLE 29 LIS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 143
TABLE 30 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
7.2.1.10 Practice management systems 144
7.2.1.10.1 Incentives offered for the use of practice management systems have attracted interest in their adoption 144
TABLE 31 PRACTICE MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 145
TABLE 32 PRACTICE MANAGEMENT SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
7.2.1.11 Clinical decision support systems 146
7.2.1.11.1 Need to minimize errors and ensure regulatory compliance is driving the adoption of CDSS 146
TABLE 33 CDSS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 146
TABLE 34 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS: END-USER ASSESSMENT (2020) 147
7.2.1.12 ePrescribing solutions 148
7.2.1.12.1 Integrated ePrescribing solutions offer significant benefits over standalone systems 148
TABLE 35 E-PRESCRIBING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 148
TABLE 36 E-PRESCRIBING SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
7.2.1.13 Radiology information systems 149
7.2.1.13.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders 149
TABLE 37 RIS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 150
TABLE 38 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.2.1.14 Computerized physician order entry systems 151
7.2.1.14.1 CPOE is regarded as a highly effective tool to minimize prescription errors 151
TABLE 39 CPOE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 151
TABLE 40 COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 152
7.2.1.15 Cardiovascular information systems 152
7.2.1.15.1 High prevalence of CVD has boosted the demand for solutions to increase care quality and effectiveness 152
TABLE 41 CVIS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 153
TABLE 42 CARDIOVASCULAR INFORMATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 153
7.2.1.16 Patient registry software 154
7.2.1.16.1 Funding from public and private organizations to support market growth 154
TABLE 43 PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 154
TABLE 44 PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
FIGURE 43 PATIENT REGISTRY SOFTWARE MARKET: END-USER ASSESSMENT (2020) 155
7.2.1.17 Infection surveillance solutions 156
7.2.1.17.1 Infection surveillance solutions minimize the human and financial impact of infections 156
TABLE 45 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
FIGURE 44 INFECTION SURVEILLANCE SOLUTIONS MARKET: END-USER ASSESSMENT (2020) 157
7.2.1.18 Radiation dose management solutions 158
7.2.1.18.1 These solutions enable the optimization of radiation dose administration and management 158
TABLE 46 RADIATION DOSE MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 158
TABLE 47 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 159
7.2.2 NON-CLINICAL HEALTHCARE IT SOLUTIONS 160
TABLE 48 NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 49 NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
7.2.2.1 Healthcare asset management solutions 161
7.2.2.1.1 Healthcare asset management solutions help in reducing costs and improving the quality of care 161
TABLE 50 HEALTHCARE ASSET MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 162
7.2.2.2 Revenue cycle management solutions 163
TABLE 51 REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 52 REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 164
7.2.2.2.1 Front-end RCM Solutions 164
7.2.2.2.1.1 Rising patient volume and subsequent growth in the demand for health insurance is supporting the growth of this market 164
TABLE 53 FRONT-END RCM SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 165
7.2.2.2.2 Mid-RCM solutions 165
7.2.2.2.2.1 Mid-RCM solutions are used to improve the accuracy of charge capturing processes, review bills, and prevent fraudulent claims 165
TABLE 54 MID-RCM SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 166
7.2.2.2.3 Back-end RCM solutions 166
7.2.2.2.3.1 Back-end RCM solutions are mainly used for the accurate payment of insurance claims and to prevent fraudulent claims 166
TABLE 55 BACK-END RCM SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 167
7.2.2.3 Healthcare analytics solutions 167
TABLE 56 HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 57 HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 168
7.2.2.3.1 Clinical analytics 169
7.2.2.3.1.1 Clinical analytics tools assist in fact-based diagnostics and therapeutic decision-making 169
TABLE 58 CLINICAL ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 169
TABLE 59 CLINICAL ANALYTICS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 169
7.2.2.3.2 Financial analytics 170
7.2.2.3.2.1 Financial analytics solutions enable healthcare organizations to analyze net collection rates and the costs of billing per invoice 170
TABLE 60 FINANCIAL ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 170
TABLE 61 FINANCIAL ANALYTICS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 171
7.2.2.3.3 Operational & administrative analytics solutions 171
7.2.2.3.3.1 These solutions allow healthcare organizations to make more informed decisions that improve cost-savings 171
TABLE 62 OPERATIONAL & ADMINISTRATIVE ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 172
TABLE 63 OPERATIONAL & ADMINISTRATIVE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 172
7.2.2.4 Customer relationship management solutions 173
7.2.2.4.1 CRM solutions facilitate effective customer care service in the healthcare industry by providing an intuitive and modular framework to enterprises 173
TABLE 64 CUSTOMER RELATIONSHIP MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 173
7.2.2.5 Pharmacy information systems 174
7.2.2.5.1 Demand for automatic refills and the growing popularity of ePrescribing will drive the use of pharmacy information systems 174
TABLE 65 PHARMACY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
7.2.2.6 Healthcare interoperability solutions 175
7.2.2.6.1 Hospitals and health systems can improve operational and clinical efficiencies with the implementation of these solutions 175
TABLE 66 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
7.2.2.7 Healthcare quality management solutions 176
7.2.2.7.1 Data security concerns and the high cost of quality reporting are expected to restrain the growth of this market 176
TABLE 67 HEALTHCARE QUALITY MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 176
7.2.2.8 Supply chain management solutions 177
TABLE 68 SUPPLY CHAIN MANAGEMENT SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 69 SUPPLY CHAIN MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 177
7.2.2.8.1 Procurement management solutions 178
7.2.2.8.1.1 Procurement management solutions form an integral part of supply chain management as they maximize profits on each purchase order 178
TABLE 70 PROCUREMENT MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 178
7.2.2.8.2 Inventory management solutions 179
7.2.2.8.2.1 Inventory management solutions play an essential role in maintaining optimum inventory levels within healthcare organizations 179
TABLE 71 INVENTORY MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 180
7.2.2.9 Medication management systems 180
TABLE 72 MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 73 MEDICATION MANAGEMENT SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 181
7.2.2.9.1 Electronic medication administration systems 182
7.2.2.9.1.1 Administrative systems offer benefits such as improved patient safety and reductions in the incidence of adverse drug effects 182
TABLE 74 ELECTRONIC MEDICATION ADMINISTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 182
7.2.2.9.2 Barcode medication administration systems 183
7.2.2.9.2.1 Barcode medication administration systems help in better inventory management 183
TABLE 75 BARCODE MEDICATION ADMINISTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 183
7.2.2.9.3 Medication inventory management systems 184
7.2.2.9.3.1 Medication inventory management systems aid hospitals and pharmacies in making purchasing decisions regarding medicines 184
TABLE 76 MEDICATION INVENTORY MANAGEMENT SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 184
7.2.2.9.4 Medication assurance systems 185
7.2.2.9.4.1 Medication assurance systems offer better disease management and improved transitional care 185
TABLE 77 MEDICATION ASSURANCE SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 185
7.2.2.10 Workforce management solutions 186
7.2.2.10.1 Workforce management solutions help healthcare organizations to improve the accuracy of employee data 186
TABLE 78 WORKFORCE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 186
7.2.2.11 Financial management systems (billing & accounting) 187
7.2.2.11.1 Increased efficiency, improved accuracy, and reduced labor costs are some of the benefits offered by financial management (accounting) systems 187
TABLE 79 FINANCIAL MANAGEMENT SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
7.2.2.12 Healthcare information exchanges 188
7.2.2.12.1 HIE solutions enable interoperability, accessibility, clinical workflow, data integrity, and security of health-related information at all points 188
TABLE 80 HEALTHCARE INFORMATION EXCHANGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 189
7.2.2.13 Medical document management solutions 189
7.2.2.13.1 Medical document management solutions offer rapid returns on investment (ROIs), high security, and increased practice profitability 189
TABLE 81 MEDICAL DOCUMENT MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 190
7.3 HEALTHCARE PAYER SOLUTIONS 191
TABLE 82 HEALTHCARE IT PAYER SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 83 HEALTHCARE IT PAYER SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 192
7.3.1 CLAIMS MANAGEMENT SOLUTIONS 192
7.3.1.1 Claims management solutions help payers manage the complex procedure of claims processing efficiently 192
TABLE 84 CLAIMS MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 193
7.3.2 POPULATION HEALTH MANAGEMENT SOLUTIONS 193
7.3.2.1 Population health management solutions help increase patient satisfaction through daily health monitoring 193
TABLE 85 KEY VENDORS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS 194
TABLE 86 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 194
7.3.3 PHARMACY AUDIT & ANALYSIS SOLUTIONS 195
7.3.3.1 Pharmacy audit & analysis solutions provide relevant information to executives to make fact-based decisions 195
TABLE 87 PHARMACY AUDIT & ANALYSIS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 195
7.3.4 PAYMENT MANAGEMENT SOLUTIONS 196
7.3.4.1 Payment management solutions connect payers, providers, members, and banks on a single, integrated network 196
TABLE 88 PAYMENT MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 196
7.3.5 CUSTOMER RELATIONSHIP MANAGEMENT SOLUTIONS 197
7.3.5.1 Healthcare payers are creating CRM strategies to meet the unique needs of their stakeholders 197
TABLE 89 CUSTOMER RELATIONSHIP MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 197
7.3.6 MEMBER ELIGIBILITY MANAGEMENT SOLUTIONS 198
7.3.6.1 These solutions provide efficient management and utilization of member eligibility data to reduce administrative and medical costs 198
TABLE 90 MEMBER ELIGIBILITY MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 198
7.3.7 FRAUD ANALYTICS SOLUTIONS 199
7.3.7.1 Fraud analytics platforms help payers improve claims processing, medical policies, provider contracts, network management, and compliance 199
TABLE 91 FRAUD ANALYTICS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 200
7.3.8 PROVIDER NETWORK MANAGEMENT SOLUTIONS 200
7.3.8.1 Payers use these solutions to improve communication with providers, increase case resolution rate, and eliminate redundant capture of provider information 200
TABLE 92 PROVIDER NETWORK MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 201
7.4 HCIT OUTSOURCING SERVICES 201
TABLE 93 HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 94 HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 202
7.4.1 IT INFRASTRUCTURE MANAGEMENT SERVICES 203
7.4.1.1 Healthcare organizations are outsourcing IT infrastructure services due to the high capital investments required to establish & maintain IT infrastructure 203
TABLE 95 IT INFRASTRUCTURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 203
7.4.2 PAYER HCIT OUTSOURCING SERVICES 204
TABLE 96 PAYER HCIT OUTSOURCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 97 PAYER HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 205
7.4.2.1 Claims management services 205
7.4.2.1.1 Outsourcing claims management leads to faster turnaround time and helps to decrease errors and costs 205
TABLE 98 CLAIMS MANAGEMENT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 206
7.4.2.2 Provider network management services 206
7.4.2.2.1 Payers outsource provider network management services to third-party vendors so that they can focus on their core functions 206
TABLE 99 PROVIDER NETWORK MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 207
7.4.2.3 Billing & accounts management services 208
7.4.2.3.1 Outsourcing billing & accounts management provides benefits such as increased cash flow, reduced burden on staff, and reduced requirement of storage space 208
TABLE 100 BILLING & ACCOUNTS MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 208
7.4.2.4 Fraud analytics services 209
7.4.2.4.1 Vendors are providing a complete suite of fraud management services to help payers manage the entire life cycle of payment fraud 209
TABLE 101 FRAUD ANALYTICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 210
7.4.2.5 Other payer HCIT outsourcing services 211
TABLE 102 OTHER PAYER HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 211
7.4.3 PROVIDER HCIT OUTSOURCING SERVICES 211
TABLE 103 PROVIDER HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 212
7.4.3.1 Revenue cycle management services 212
7.4.3.1.1 Hospitals are outsourcing RCM processes because setting up IT infrastructure for RCM can be very expensive for small and medium-sized healthcare organizations 212
TABLE 104 REVENUE CYCLE MANAGEMENT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 213
7.4.3.2 EMR/medical document management services 213
7.4.3.2.1 EMR management services include creating, archiving, maintaining, and retrieving electronic medical records as required 213
TABLE 105 EMR/MEDICAL DOCUMENT MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 214
7.4.3.3 Laboratory information management services 214
7.4.3.3.1 Effective laboratory information management provides benefits such as fast reporting and access to queries and better accuracy & overall productivity 214
TABLE 106 LABORATORY INFORMATION MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 215
7.4.3.4 Other provider HCIT outsourcing services 215
TABLE 107 OTHER PROVIDER HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 216
7.4.4 OPERATIONAL HCIT OUTSOURCING SERVICES 216
TABLE 108 OPERATIONAL HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 217
7.4.4.1 Supply chain management services 217
7.4.4.1.1 SCM provides a wide range of capabilities from automating data capture to facilitating supply chain design 217
TABLE 109 SUPPLY CHAIN MANAGEMENT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 218
7.4.4.2 Business process management services 218
7.4.4.2.1 BPM systems provide a systematic approach to aligning internal business functions with customer needs 218
TABLE 110 BUSINESS PROCESS MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 219
7.4.4.3 Other operational HCIT outsourcing services 220
TABLE 111 OTHER OPERATIONAL HCIT OUTSOURCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 220
8 HEALTHCARE IT MARKET, BY COMPONENT 221
8.1 INTRODUCTION 222
TABLE 112 HEALTHCARE IT MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 222
8.2 SERVICES 222
8.2.1 DEMAND FOR SERVICES HAS INCREASED DUE TO THE INTRODUCTION OF COMPLEX SOFTWARE 222
TABLE 113 HEALTHCARE IT SERVICES OFFERED BY KEY MARKET PLAYERS 223
TABLE 114 HEALTHCARE IT SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 224
8.3 SOFTWARE 224
8.3.1 HEALTHCARE ORGANIZATIONS ARE MOVING FROM ON-PREMISE MODELS TO WEB- AND CLOUD-BASED MODELS FOR CORE APPLICATIONS 224
TABLE 115 HEALTHCARE IT SOFTWARE OFFERED BY KEY MARKET PLAYERS 225
TABLE 116 HEALTHCARE IT SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 226
8.4 HARDWARE 227
8.4.1 NEED FOR FREQUENT HARDWARE UPGRADES TO KEEP UP WITH SOFTWARE ADVANCEMENTS IS DRIVING MARKET GROWTH 227
TABLE 117 HEALTHCARE IT HARDWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 228
9 HEALTHCARE IT MARKET, BY END USER 229
9.1 INTRODUCTION 230
TABLE 118 HEALTHCARE IT MARKET, BY END USER, 2019–2026 (USD MILLION) 230
9.2 HEALTHCARE PROVIDERS 230
TABLE 119 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 120 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION) 231
9.2.1 HOSPITALS 232
9.2.1.1 Growing need to improve the profitability of healthcare operations is driving the use of HCIT tools in hospitals 232
TABLE 121 HEALTHCARE IT MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 233
9.2.2 AMBULATORY CARE CENTERS 233
9.2.2.1 Supportive government norms and incentives for healthcare IT solutions and services to support market growth 233
TABLE 122 HEALTHCARE IT MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 234
9.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES 235
9.2.3.1 Growing need for long-term home care to drive market growth 235
TABLE 123 HEALTHCARE IT MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION) 235
9.2.4 DIAGNOSTIC & IMAGING CENTERS 236
9.2.4.1 Growing burden of various chronic diseases to propel market growth 236
TABLE 124 HEALTHCARE IT MARKET FOR DIAGNOSTIC & IMAGING CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 236
9.2.5 PHARMACIES 237
9.2.5.1 HCIT solutions help pharmacies by improving workflows and minimizing error occurrence 237
TABLE 125 HEALTHCARE IT MARKET FOR PHARMACIES, BY COUNTRY,
2019–2026 (USD MILLION) 237
9.3 HEALTHCARE PAYERS 238
TABLE 126 HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2019–2026 (USD MILLION) 238
TABLE 127 HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY,
2019–2026 (USD MILLION) 239
9.3.1 PRIVATE PAYERS 239
9.3.1.1 Solutions such as RCM help private payers increase operational efficiency 239
TABLE 128 HEALTHCARE IT MARKET FOR PRIVATE PAYERS, BY COUNTRY,
2019–2026 (USD MILLION) 240
9.3.2 PUBLIC PAYERS 240
9.3.2.1 Focus on developing outcome-based payment models has driven the demand for payer HCIT solutions 240
TABLE 129 HEALTHCARE IT MARKET FOR PUBLIC PAYERS, BY COUNTRY,
2019–2026 (USD MILLION) 241

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127